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background: Catheter ablation has been used to treat incessant ventricular tachycardia (VT) and also to prevent or reduce the frequency of 
episodes of VT in patients with ischemic cardiomyopathy. However, there are limited data regarding the complications and in-hospital mortality after 
catheter ablation for ischemic VT.
methods: We used the 2002-2011 Nationwide Inpatient Sample (NIS) databases to identify all patients aged ≥18 years with a primary diagnosis 
of VT (ICD-9-CM code 427.1) and who also had a secondary diagnosis of prior history of myocardial infarction (ICD-9-CM 412). Patients with 
supraventricular arrhythmias were excluded. Patients who underwent catheter ablation were identified using ICD-9-CM procedure code 37.34. 
Mantel-Haenszel χ2 test of linear association was used to examine trends in catheter ablation, its in-hospital complications, and in-hospital 
mortality.
results: From 2002 to 2011, among 81,539 patients admitted with ischemic VT, 4,653 (5.7%) underwent catheter ablation. The proportion of 
patients with ischemic VT who underwent catheter ablation increased significantly from 2.8% in 2002 to 10.8% in 2011 (ptrend <0.001). The overall 
rate of any in-hospital complication was 11.2% (523/4,653) with vascular complications (6.9%) being the most common. Other complications 
included cardiac (4.3%), respiratory (4.3%), and neurological (0.5%). In-hospital mortality associated with catheter ablation for ischemic VT was 
1.6% (75/4,653). From 2002 to 2011, there was no significant change in the overall complication rate (8.4% to 10.2%, ptrend = 0.101; adjusted 
OR 0.97, 95% CI 0.56-1.66) and in-hospital mortality (1.3% to 1.8%, ptrend = 0.266; adjusted OR 0.45, 95% CI 0.11-1.80) following catheter 
ablation for ischemic VT.
conclusions: Catheter ablation utilization rates in patients with ischemic VT have increased over the past 10 years. In-hospital complication rates 
and in-hospital mortality following the procedure have not changed significantly.
